ÂÜÀòÂÒÂ×

Ann Christine Korsgaard has over 20 years of experience in Regulatory Affairs. Since 2018, they have served as the CEO of Ozack ApS, VP Regulatory Affairs of AFYX Therapeutics, and External Associate Professor at Københavns Universitet, where they lead the mandatory module "Clinical Development - Efficacy of Medicines" as part of the Master of Medicines Regulatory Affairs. From 2016 to 2018, they were the Managing Director & Regulatory Affairs Executive at Biotrack ApS, Senior Director and Vice President Regulatory Affairs EU & Intl. at UCB, and Senior Director Regulatory Affairs at RhoVac. From 2006 to 2015, they held various positions at Genmab, including Vice President Regulatory Affairs, Senior Director Regulatory Affairs, Director Regulatory Affairs, and Global Regulatory Project Leader. In 2005, they were Vice President Project Management & Regulatory Affairs at Action Pharma and Director International Registration at Actavis A/S, where they were responsible for the international regulatory team leadership of 30 FTEs and the Pharmacovigilance function to ensure European compliance.

Ann Christine Korsgaard's education history includes completing a Board Certificate from Board Assure A/S in 2018, an MMPI from SIMI Scandinavian International Management Institute in 1999, a Master's degree from Danmarks Farmaceutiske Universitet between 1985 and 1990, studies in Mathematics/Biologics at Hasseris Gymnasium from 1981 to 1984, and studies at Stolpedalsskolen from 1976 to 1981.